Can AI-Powered MRI analysis outsmart prostate cancer?

NCT ID NCT06126172

Ongoing Knowledge-focused Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether detailed analysis of MRI scans (called radiomics) can better predict how aggressive a prostate cancer is and whether it will come back soon after surgery. Researchers will study 125 men with prostate cancer who have an MRI before treatment. The goal is to improve risk assessment so that patients get the right level of treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multiparametric magnetic resonance imaging (mpMRI) with radiomics analysis
What this could lead to: If successful, this could help doctors more accurately determine which prostate cancers are aggressive and need immediate treatment versus those that can be safely monitored.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly benefit participants. The results may not change current practice until confirmed in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Li-Jen Wang

Taoyuan, Taiwan, 333, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.